Normal telomere lengths in naive and memory CD4+ T cells in HIV type 1 infection: A mathematical interpretation

AIDS Research and Human Retroviruses

Volumn 15, Issue 12, 1999, Pages 1053-1062

  Wolthers, Katja C ^a   Noest, André J ^b   Otto, Sigrid A ^a   Miedema, Frank ^a   De Boer, Rob J ^b  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CD45 ANTIGEN; CELL DNA;

ANTIGEN EXPRESSION; ARTICLE; CHROMOSOME ANALYSIS; CLINICAL ARTICLE; CLINICAL FEATURE; COMPARTMENT MODEL; CONTROLLED STUDY; DATA ANALYSIS; DNA DETERMINATION; HELPER CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE DEPLETION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RESTRICTION FRAGMENT; TELOMERE; VALIDATION PROCESS; VIRUS CELL INTERACTION;

CD4-POSITIVE T-LYMPHOCYTES; CROSS-SECTIONAL STUDIES; HIV INFECTIONS; HIV-1; HUMANS; IMMUNOLOGIC MEMORY; LONGITUDINAL STUDIES; MODELS, THEORETICAL; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; TELOMERE;

EID: 0033543120     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/088922299310340     Document Type: Article

References (53)

1. Schuitemaker H, Koot M, Kootstra NA, Dercksen MW, De Goede RE, Van Steenwijk RP, Lange JM, Schattenkerk JK, Miedema F, and Tersmette M: Biological phenotype of human immunodeficiency virus type 1 clones at different stages of infection: Progression of disease is associated with a shift from monocytotropic to T-cell-tropic virus population. J Virol 1992;66:1354-1360.
2. Ho DD, Neuman AU, Perelson AS, Chen W, Leonard JM, and Markowitz M: Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature (London) 1995;373:123-126.
3. Wei X, Ghosh SK, Taylor ME, Johnson VA, Emini EA, Deutsch P, Lifson JD, Bonhoeffer S, Nowak MA, Hahn BH, et al.: Viral dynamics in human immunodeficiency virus type 1 infection. Nature (London) 1995;373:117-122.
4. Sprent J and Tough D: HIV results in the frame. CD4+ cell turnover. Nature (London) 1995;375:194.
5. Mosier DE: HIV results in the frame. CD4+ cell turnover. Nature (London) 1995;375:193-194.
6. Autran B, Carcelain G, Li TS, Blanc C, Mathez D, Tubiana R, Katlama C, Debre P and Leibowitch J: Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease. Science 1997;277:112-116.
7. Pakker NG, Notermans DW, De Boer RJ, Roos MT, De Wolf F, Hill A, Leonard JM, Danner SA, Miedema F, and Schellekens PT: Biphasic kinetics of peripheral blood T cells after triple combination therapy in HIV-1 infection: A composite of redistribution and proliferation. Nature Med 1998;4:208-214.
8. Zhang ZQ, Notermans DW, Sedgewick G, Cavert W, Wietgrefe S, Zupancic M, Gebhard K, Henry K, Boies L, Chen Z, Jenkins M, Mills R, McDade H, Goodwin C, Schuwirth CM, Danner SA, and Haase AT: Kinetics of CD4+ T cell repopulation of lymphoid tissues after treatment of HIV-1 infection. Proc Natl Acad Sci USA 1998;95:1154-1159.
9. + T-cell renewal in early HIV-1 infection: Effect of highly active antiretroviral therapy. Nature Med 1998;4:794-801.
10. Hellerstein M, Hanley MB, Cesar D, Siler S, Papageorgopoulos C, Wieder E, Schmidt D, Hoh R, Neese R, Macallan D, Decks S, and McCune JM: Directly measured kinetics of circulating T lymphocytes in normal and HIV-1-infected humans. Nature Med 1999;5:83-89.
11. + T cell turnover. Science 1996;274:1543-1547.
12. + cells from HIV-discordant monozygotic twins. J Exp Med 1997;185:1381-1386.
13. Blackburn EH: Structure and function of telomeres. Nature (London) 1991;350:569-573.
14. Linskens MH, Harley CB, West MD, Campisi J, and Hayflick L: Replicative senescence and cell death. Science 1995;267:17.
15. Vaziri H, Schachter F, Uchida I, Wei L, Zhu X, Effros R, Cohen D, and Harley CB: Loss of telomeric DNA during aging of normal and trisomy 21 human lymphocytes. Am J Hum Genet 1993;52:661-667.
16. Hellerstein MK and McCune JM: T cell turnover in HIV-1 disease. Immunity 1997;7:583-589.
17. Hiyama K, Hirai Y, Kyoizumi S, Akiyama M, Hiyama E, Piatyszek MA, Shay JW, Ishioka S, and Yamakido M: Activation of telomerase in human lymphocytes and hematopoietic progenitor cells. J Immunol 1995;155:3711-3715.
18. Bodnar AG, Kim NW, Effros RB, and Chiu CP: Mechanism of telomerase induction during T cell activation. Exp Cell Res 1996;228:58-64.
19. Weng NP, Levine BL, June CH, and Hodes RJ: Regulated expression of telomerase activity in human T lymphocyte development and activation. J Exp Med 1996;183:2471-2479.
20. Weng N, Levine BL, June CH, and Hodes RJ: Regulation of telomerase RNA template expression in human T lymphocyte development and activation. J Immunol 1997;158:3215-3220.
21. Wolthers KC, Otto SA, Wisman GB, Fleury S, Reiss P, Ten Kate RW, Van der Zee AG, and Miedema F: Normal T-cell telomerase activity and upregulation in human immunodeficiency virus-1 infection. Blood 1999;93:1011-1019.
22. Perelson AS, Essunger P, and Ho DD: Dynamics of HIV-1 and CD4+ lymphocytes in vivo. AIDS 1997;11A:S17-S24.
23. Weng NP, Levine BL, June CH, and Hodes RJ: Human naive and memory T lymphocytes differ in telomeric length and replicative potential. Proc Natl Acad Sci USA 1995;92:11091-11094.
24. Schnittman SM, Lane HC, Greenhouse J, Justement JS, Baseler M, and Fauci AS: Preferential infection of CD4+ memory T cells by human immunodeficiency virus type 1: Evidence for a role in the selective T-cell functional defects observed in infected individuals. Proc Natl Acad Sci USA 1990;87:6058-6062.
25. Giorgi JV: Phenotype and function of T cells in HIV disease. In: Immunology of HIV Infection (Gupta S, ed.). Plenum Press, New York, 1996, pp. 181-199.
26. + T-cell repertoire that are not immediately restored by antiviral or immune-based therapies. Nature Med 1997;3: 533-540.
27. Harley CB, Futcher AB, and Greider CW: Telomeres shorten during ageing of human fibroblasts. Nature (London) 1990;345: 458-460.
28. Pommier JP, Gauthier L, Livartowski J, Galanaud P, Boue F, Dulioust A, Marce D, Ducray C, Sabatier L, Lebeau J, and Boussin FD: Immunosenescence in HIV pathogenesis. Virology 1997; 231:148-154.
29. Bukrinsky MI, Stanwick TL, Dempsey MP, and Stevenson M: Quiescent T lymphocytes as an inducible virus reservoir in HIV-1 infection. Science 1991;254:423-427.
30. De Boer RJ and Noest AJ: T cell renewal rates, telomerase, and telomere length shortening. J Immunol 1998;160:5832-5837.
31. + T-lymphocyte regeneration after intensive chemotherapy. N Engl J Med 1995;332:143-149.
32. Mackall CL, Hakim FT, and Gress RE: T-cell regeneration: All repertoires are not created equal. Immunol Today 1997;18:245-251.
33. 32a. Bunce C and Bell EB: CD45RC isoforms define two types of CD4 memory T cells, one of which depends on persisting antigen. J Exp Med 1997;185:767-776:
34. 32b. Mackall CL and Gress RE: Pathways of T-cell regeneration in mice and humans: Implications for bone marrow transplantation and immunotherapy. Immunol Rev 1997;157:61-72.
35. +) T-helper cells after human allogencic bone marrow transplantation. Blood 1997;90: 850-857.
36. Fauci AS: Multifactorial nature of human immunodeficiency virus disease: Implications for therapy. Science 1993;262:1011-1018.
37. Mohri H, Bonhoeffer S, Monard S, Perelson AS, and Ho DD: Rapid turnover of T lymphocytes in SIV-infected rhesus macaques. Science 1998;279:1223-1227.
38. + T-cell turnover in HIV-1 infection: A paradigm revisited. Immunol Today 1998;19:44-48.
39. + cell subset in HIV disease implicate replicative senescence in HIV pathogenesis. AIDS 1996;F17-22.
40. + lymphocytes in HIV-1 infection as measured by Ki-67 antigen. J Exp Med 1998;187:1295-1303.
41. Tenner-Racz K, Stellbrink HJ, Van Lunzen J, Schneider C, Jacobs JP, Raschdorff B, Grosschupff G, Steinman RM, and Racz P: The unenlarged lymph nodes of HIV-1-infected, asymptomatic patients with high CD4 T cell counts are sites for virus replication and CD4 T cell proliferation. The impact of highly active antiretroviral therapy. J Exp Med 1998;187:949-959.
42. + T lymphocyte turnover in simian immunodeficiency virus-infected macaques. Proc Natl Acad Sci USA 1998;95:6388-6393.
43. Chun TW, Carruth L, Finzi D, Shen X, DiGiuseppe JA, Taylor H, Hermankova M, Chadwick K, Margolick J, Quinn TC, Kuo YH, Brookmeyer R, Zeiger MA, Barditch-Crovo P, and Siliciano RF: Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection. Nature (London) 1997;387:183-188.
44. Rep MH, Van Oosten BW, Roos MT, Ader HJ, Polman CH, and Van Lier RA: Treatment with depleting CD4 monoclonal antibody results in a preferential loss of circulating naive T cells but does not affect IFN-γ secreting TH1 cells in humans. J Clin Invest 1997;99:2225-2231.
45. Moreland LW, Bucy RP, and Koopman WJ: Regeneration of T cells after chemotherapy. N Engl J Med 1995;332:1651-1652.
46. Clark DR, De Boer RJ, Wolthers KC, and Miedema F: T cell dynamics in HIV-1 infection. Adv Immun 1999 (in press).
47. McCune JM, Loftus R, Schmidt DK, Carroll P, Webster D, Swor-Yim LB, Francis IR, Gross BH, and Grant RM: High prevalence of thymic tissue in adults with human immunodeficiency virus-1 infection. J Clin Invest 1998;101:2301-2308.
48. Bonyhadi ML, Rabin L, Salimi S, Brown DA, Kosek J, McCune JM, and Kaneshima H: HIV induces thymus depletion in vivo. Nature (London) 1993;363:728-732.
49. Douek DC, McFarland RD, Keiser PH, Gage EA, Massey JM, Haynes BF, Polis MA, Haase AT, Feinberg MB, Sullivan JL, Jamieson BD, Zack JA, Picker LJ, and Koup RA: Changes in thymic function with age and during the treatment of HVI infection. Nature (London) 1998;396:690-695.
50. Haynes BF, Hale LP, Weinhold KJ, Patel DD, Liao HX, Bressler PB, Jones DM, Demarest JF, Gebhard-Mitchell K, Haase AT, and Bartlett JA: Analysis of the adult thymus in reconstitution of T lymphocytes in HIV-1 infection. J Clin Invest 1999;103:453-460.
51. Kaneshima H, Su L, Bonyhadi ML, Connor RI, Ho DD, and McCune JM: Rapid-high, syncytium-inducing isolates of human immunodeficiency virus type 1 induce cytopathicity in the human thymus of the SCID-hu mouse. J Virol 1994;68:8188-8192.
52. Roederer M, Dubs JG, Anderson MT, Raju PA, Herzenberg LA, and Herzenberg LA: CDS naive T cell counts decrease progressively in HIV-infected adults. J Clin Invest 1995;95:2061-2066.
53. Clark DR, Ampel NM, Hallett CA, Yedavalli VR, Ahmad N, and DeLuca D: Peripheral blood from human immunodeficiency virus type 1-infected patients displays diminished T cell generation capacity. J Infect Dis 1997;176:649-654.